All I have to say is I'll stick with the product, it efficacy,...

All I have to say is I'll stick with the product, it efficacy, and the demand in the world (which is there) but "pandemicafied". The case studies are there, it works, (unless I've missed something here and it doesn't actually work), It was going well until the accounting 'incident' and COVID. I'm quietly confident this will bounce back, but it will take a few more years. The factory in China did not cost a lot and expansion was quite cheap. I expect one in the US would be more but not a problem - it's a 'dirt farm'.